Retrospectively Investigating Longitudinal Outcomes in MED-EL SONATA 2 Cochlear Implant Recipients.
Key facts
- Where
- Madrid and Valencia, SpainSee the 2 sites
Where in Spain
- Hospital Universitario La PazMadrid, SpainContact: Luis Lassaletta Atienza, Dr.Taking people
- Hospital Universitario Y Politecnico La FeValencia, SpainContact: Laura Cavallé Garrido, Dr.Not yet recruiting
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- MED-EL Elektromedizinische Geräte GmbH
- Trial code
- NCT07697911
- Record updated
- 5 November 2026
- Original description
MED-EL Cochlear Implants (CI) provide auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing-impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.Read full original descriptionShow less
Longitudinal Outcomes of SONATA 2 Cochlear Implant Recipients: a Retrospective Study
MED-EL Cochlear Implants (CI) provide auditory sensations via electrical stimulation of the auditory pathways for severely to profoundly hearing-impaired individuals who obtain little or no benefit from acoustic amplification in the best aided condition.
However, there is only few evidence from large long-term observational studies available to gain knowledge on clinical effectiveness of cochlear implants. With continued pressure on healthcare system budgets, there is an increasing demand for evidence-based research that demonstrates an intervention is effective in the real-world environment across large and diverse populations. Currently, there is a paucity of data concerning the long-term outcomes of subjects implanted with a SONATA 2 cochlear implant from representative samples of the population. This retrospective study aims at analyzing SONATA 2 cochlear implant data from clinical routine.
Inclusion: At least one MED-EL SONATA 2 cochlear implant with a compatible MED-EL audio processor.
Exclusion: Lack of compliance with any inclusion criteria.